Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer

被引:72
作者
Jereczek-Fossa, Barbara A. [1 ,7 ]
Fariselli, Laura [5 ,6 ]
Beltramo, Giancarlo [5 ]
Catalano, Gianpiero [1 ]
Serafini, Flavia [1 ]
Garibaldi, Cristina [2 ]
Cambria, Raffaella [2 ]
Brait, Lorenzo [5 ]
Possanzini, Marco [5 ]
Bianchi, Livia C. [5 ]
Vavassori, Andrea [1 ]
Zerini, Dario [1 ]
Orsi, Franco [4 ]
de Cobelli, Ottavio [3 ,7 ]
Orecchia, Roberto [1 ,7 ]
机构
[1] European Inst Oncol, Dept Radiotherapy, I-20141 Milan, Italy
[2] European Inst Oncol, Dept Med Phys, I-20141 Milan, Italy
[3] European Inst Oncol, Dept Urol, I-20141 Milan, Italy
[4] European Inst Oncol, Unit Intervent Radiol, I-20141 Milan, Italy
[5] Cyberknife Ctr CDI, Milan, Italy
[6] Carlo Besta Neurol Inst Fdn, Radiotherapy Unit, Milan, Italy
[7] Univ Milan, Milan, Italy
关键词
Recurrent prostate cancer; Lymph node recurrence; Stereotactic radiotherapy; Robotic stereotactic radiotherapy; BODY RADIATION-THERAPY; SALVAGE RADIOTHERAPY; RADIOSURGERY; METASTASES; ONCOLOGY;
D O I
10.1016/j.radonc.2009.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report on 14 patients treated with linac- or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrence from prostate cancer, up to the mean dose of 30 Gy/3 fractions. At the mean follow-up of 18.6 months, five patients experienced clinical out-field progression. Toxicity was minimal. Further investigation is warranted in order to identify the patients that benefit most from this treatment modality and to define the optimal association of such local approach with androgen deprivation. Hopefully, effective local therapy might reduce the burden of systemic therapies given to the recurrent/metastatic prostate cancer patients. (C) 2009 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 93 (2009) 14-17
引用
收藏
页码:14 / 17
页数:4
相关论文
共 23 条
[1]  
[Anonymous], 2016, COMPR CANC NETW
[2]   The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: A systematic review of the literature [J].
Calcerrada Diaz-Santos, Nieves ;
Blasco Amaro, Juan Antonio ;
Ariza Cardiel, Gloria ;
Andradas Aragones, Elena .
RADIOTHERAPY AND ONCOLOGY, 2008, 89 (03) :245-253
[3]   Stereotactic body radiation therapy - A comprehensive review [J].
Chang, Brian K. ;
Timmerman, Robert D. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (06) :637-644
[4]   TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) [J].
COX, JD ;
STETZ, J ;
PAJAK, TF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1341-1346
[5]   The role of whole pelvic radiotherapy in locally advanced prostate cancer [J].
Dirix, Piet ;
Haustermans, Karin ;
Junius, Sara ;
Withers, Rodney ;
Oyen, Raymond ;
Van Poppel, Hendrik .
RADIOTHERAPY AND ONCOLOGY, 2006, 79 (01) :1-14
[6]   Prospective evaluation of urinary and intestinal side effects after BeamCath® stereotactic dose-escalated radiotherapy of prostate cancer [J].
Fransson, P ;
Bergström, P ;
Löfroth, PO ;
Widmark, A .
RADIOTHERAPY AND ONCOLOGY, 2002, 63 (03) :239-248
[7]   Image-guided robotic radiosurgery for spinal metastases [J].
Gibbs, Iris C. ;
Kamnerdsupaphon, Pimkhuan ;
Ryu, Mi-Ryeong ;
Dodd, Robert ;
Kiernan, Michaela ;
Change, Steven D. ;
Adler, John R., Jr. .
RADIOTHERAPY AND ONCOLOGY, 2007, 82 (02) :185-190
[8]   Prostate cancer relapse after therapy with curative intention: A diagnostic and therapeutic dilemma [J].
Gronau, E ;
Goppelt, M ;
Harzmann, R ;
Weckermann, D .
ONKOLOGIE, 2005, 28 (6-7) :361-366
[9]   The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer [J].
Iversent, Peter ;
Roder, Martin Andreas .
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) :361-369
[10]   Evidence-based radiation oncology: Definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer [J].
Jereczek-Fossa, Barbara Alicja ;
Orecchia, Roberto .
RADIOTHERAPY AND ONCOLOGY, 2007, 84 (02) :197-215